Volitionrx limited announces full fiscal year 2024 financial results and business update

Conference call to discuss financial and operational results scheduled for monday, march 31 at 4:30 p.m. u.s. eastern time henderson, nevada , march 31, 2025 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, today announces financial results and a business update for the fourth quarter and full fiscal year ended december 31, 2024.
VNRX Ratings Summary
VNRX Quant Ranking